These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 11119927)

  • 1. Immunity in maintenance immunosuppression with and without cyclosporine in long-term kidney transplant recipients.
    Yamashita M; Aikawa A
    Transplant Proc; 2000 Nov; 32(7):1768-72. PubMed ID: 11119927
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term results in mizoribine-treated renal transplant recipients: a prospective, randomized trial of mizoribine and azathioprine under cyclosporine-based immunosuppression.
    Tanabe K; Tokumoto T; Ishikawa N; Kanematsu A; Oshima T; Harano M; Inui M; Yagisawa T; Nakajima I; Fuchinoue S; Takahashi K; Toma H
    Transplant Proc; 1999 Nov; 31(7):2877-9. PubMed ID: 10578323
    [No Abstract]   [Full Text] [Related]  

  • 3. Degree and sequential change of peripheral blood microchimerism in renal transplant recipients.
    Aikawa A; Yamashita M; Arai K; Hirayama N; Ohara T; Hasegawa A; Kaneshige T; Hirai H
    Transplant Proc; 1996 Jun; 28(3):1288-90. PubMed ID: 8658663
    [No Abstract]   [Full Text] [Related]  

  • 4. Early steroid withdrawal after kidney transplantation.
    Yagisawa T; Toma H; Ota K; Tanabe K; Ishikawa N; Tokumoto N; Yaguchi H; Nakada T
    Transplant Proc; 1996 Jun; 28(3):1342-5. PubMed ID: 8658686
    [No Abstract]   [Full Text] [Related]  

  • 5. The clinical relevance of pretransplant recipient immunoresponsiveness in renal transplantation: impact on rejection.
    Renna Molajoni E; Cinti P; Evangelista B; Poli L; Cocciolo P; Berloco P; Cortesini R
    Transplant Proc; 1996 Feb; 28(1):402-3. PubMed ID: 8644290
    [No Abstract]   [Full Text] [Related]  

  • 6. Conversion of renal transplant immunosuppression from tacrolimus (FK 506) to cyclosporine: a single center experience.
    Ichikura H; Tanabe K; Tokumoto T; Shimuzu T; Ishikawa N; Harano M; Inui M; Manu M; Ito S; Shimmura H; Okuda H; Yagisawa T; Fuchinoue S; Toma H
    Transplant Proc; 2000 Nov; 32(7):1733-5. PubMed ID: 11119911
    [No Abstract]   [Full Text] [Related]  

  • 7. Results with histological diagnosis in kidney transplant rejections treated with 15-deoxyspergualin.
    Kyo M; Ichikawa Y; Hanafusa T; Fukunishi T; Nagano S; Takahara S; Kokado Y; Okuyama A; Ihara H; Ito K; Sagawa S; Sonoda T; Akiyama T; Kurita T; Suzuki S; Amemiya H
    Transplant Proc; 1996 Apr; 28(2):910-1. PubMed ID: 8623457
    [No Abstract]   [Full Text] [Related]  

  • 8. Quadruple immunotherapy will promise excellent graft survival in cadaveric renal transplants using cardiac arrest donor grafts.
    Hoshinaga K; Shiroki R; Higuchi T; Horiba Y; Yanaoka M; Naide Y
    Transplant Proc; 1996 Jun; 28(3):1591-3. PubMed ID: 8658798
    [No Abstract]   [Full Text] [Related]  

  • 9. Soluble IL-2R assay and spontaneous blastogenesis in the immunological monitoring of kidney transplant patients.
    de Boccardo G; Albano S; Alvarellos T; Massari P; Giraudo C
    Transplant Proc; 1994 Oct; 26(5):2854-6. PubMed ID: 7940899
    [No Abstract]   [Full Text] [Related]  

  • 10. Induction of donor-specific tolerance or sensitization as measured by sequential MLC reactivity up to 24 months after renal transplantation.
    Kahn D; du Toit E; Jacobson JE; Creemers P
    Transpl Int; 1994; 7 Suppl 1():S287-9. PubMed ID: 11271227
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of different anti-rejection regimens on the expression of differentiation and activation markers on the surface of host lymphocytes.
    Malinowski K; Ye H; Waltzer WC
    Transplant Proc; 2000 Jun; 32(4):773-5. PubMed ID: 10856579
    [No Abstract]   [Full Text] [Related]  

  • 12. Therapeutic approach with patient-specific cyclosporine administration protocol in renal transplantation.
    Sernyak PS; Chernobrivtsev PA; Kalinin DI; Lunyova AG; Denisov VK
    Transplant Proc; 1997; 29(1-2):296. PubMed ID: 9123003
    [No Abstract]   [Full Text] [Related]  

  • 13. Excellent long-term survival of low-risk, first renal allografts using cyclosporine/azathioprine double therapy.
    Faull RJ; Bannister KM; Russ GR; Mathew TH; Clarkson AR
    Transplant Proc; 1999; 31(1-2):1155-6. PubMed ID: 10083516
    [No Abstract]   [Full Text] [Related]  

  • 14. Experience with administration of 15-deoxyspergualin in rejection in kidney transplant recipients.
    Jiang H; Takahara S; Takano Y; Kokado Y; Kameoka H; Moutabarrik A; Ishibashi M; Okuyama A; Sonoda T
    Transplant Proc; 1992 Oct; 24(5):1726-9. PubMed ID: 1412813
    [No Abstract]   [Full Text] [Related]  

  • 15. Quadruple immunosuppressive therapy with low-dose cyclosporine provides superior kidney transplant outcome using grafts of non-heart-beating uncontrolled cadavers.
    Shiroki R; Hoshinaga K; Tsukiashi Y; Higuchi T; Izumitani M; Horiba M; Naide Y
    Transplant Proc; 1997 Dec; 29(8):3571-3. PubMed ID: 9414841
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunosuppression with low-dose cyclosporine, mizoribine, and steroids in living-related kidney transplantation.
    Takeuchi N; Ohshima S; Matsuura O; Ono Y; Katoh N; Yamada S; Fujita T; Kinukawa T; Hirabayashi S; Sahashi M
    Transplant Proc; 1994 Aug; 26(4):1907-9. PubMed ID: 8066621
    [No Abstract]   [Full Text] [Related]  

  • 17. Is sensitivity to cyclosporine influenced by the HLA-DR phenotype of kidney graft recipients?
    Kyriakopoulos G; Antoniadis A; Gakis D; Papanikolaou V
    Transplant Proc; 1996 Dec; 28(6):3294-5. PubMed ID: 8962278
    [No Abstract]   [Full Text] [Related]  

  • 18. Infectious complications in renal transplant recipients: a 10-year review of cyclosporine-based immunosuppression.
    Tsai MK; Lee PH; Hu RH; Lee CJ
    Transplant Proc; 1998 Nov; 30(7):3125-6. PubMed ID: 9838381
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of a novel immunosuppressive agent, deoxyspergualin, on rejection in kidney transplant recipients.
    Takahashi K; Ota K; Tanabe K; Oba S; Teraoka S; Toma H; Agishi T; Kawaguchi H; Ito K
    Transplant Proc; 1990 Aug; 22(4):1606-12. PubMed ID: 2389420
    [No Abstract]   [Full Text] [Related]  

  • 20. Early fluctuation in cyclosporine A trough levels affects long-term outcome of kidney transplants.
    Inoue S; Beck Y; Nagao T; Uchida H
    Transplant Proc; 1994 Oct; 26(5):2571-3. PubMed ID: 7940795
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.